These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 729630)

  • 41. Electrophysiological effects of diphenylhydantoin on canine purkinje fibers.
    Bigger JT; Bassett AL; Hoffman BF
    Circ Res; 1968 Feb; 22(2):221-36. PubMed ID: 5639040
    [No Abstract]   [Full Text] [Related]  

  • 42. Cardiac electrophysiologic effects of AHR 5360C.
    Viamonte VM; Hamra M; Rosen MR
    Eur J Pharmacol; 1988 Feb; 146(2-3):215-22. PubMed ID: 3371397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Differential effects of a new anti-arrhythmia agent (propafenon) on the Purkinje and myocardial activity filaments].
    Bolte HD; Bergmann M; Tebbe U
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1239-42. PubMed ID: 1029968
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of tetrodotoxin, lidocaine, verapamil, and AHR-2666 on Ouabain-induced delayed afterdepolarizations in canine Purkinje fibers.
    Rosen MR; Danilo P
    Circ Res; 1980 Jan; 46(1):117-24. PubMed ID: 7349912
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of l-penbutolol (Hoe 893d) on the transmembrane potentials of canine purkinje fibers and ventricular muscle fibers.
    Kodama I; Shimizu T; Iwamura N; Hirata Y; Toyama J; Yamada K
    Arch Int Pharmacodyn Ther; 1978 Feb; 231(2):232-42. PubMed ID: 25633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of antiarrhythmic drugs on triggered sustained rhythmic activity in cardiac Purkinje fibers.
    Arnsdorf MF
    J Pharmacol Exp Ther; 1977 Jun; 201(3):689-700. PubMed ID: 577217
    [No Abstract]   [Full Text] [Related]  

  • 47. Different toxic effects of ouabain and 16-epi-gitoxin on Purkinje fibres and ventricular muscle fibres.
    Nowak G; Haustein KO
    Pharmacology; 1976; 14(3):256-64. PubMed ID: 959324
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Observations on the effects of selected antiarrhythmic drugs on mammalian cardiac purkinje fibers with two levels of steady-state potential: influences of lidocaine, phenytoin, propranolol, disopyramide and procainamide on repolarization, action potential shape and conduction.
    Arnsdorf MF; Mehlman DJ
    J Pharmacol Exp Ther; 1978 Dec; 207(3):983-91. PubMed ID: 731444
    [No Abstract]   [Full Text] [Related]  

  • 49. Analysis of the hyperpolarizing effect of catecholamines on canine cardiac Purkinje fibres.
    Neto FR; Sperelakis N
    Br J Pharmacol; 1989 Mar; 96(3):591-8. PubMed ID: 2720294
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.
    Carmeliet E
    Acta Cardiol Suppl; 1980; (25):5-25. PubMed ID: 6246694
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of verapamil on canine Purkinje fibres and ventricular muscle fibres with particular reference to the alternation of action potential duration after a sudden increase in driving rate.
    Hirata Y; Kodama I; Iwamura N; Shimizu T; Toyama J; Yamada K
    Cardiovasc Res; 1979 Jan; 13(1):1-8. PubMed ID: 445526
    [No Abstract]   [Full Text] [Related]  

  • 52. Ethanol-induced electrophysiological alterations in canine cardiac Purkinje fibers.
    Snoy FJ; Harker RJ; Thies W; Greenspan K
    J Stud Alcohol; 1980 Nov; 41(11):1023-30. PubMed ID: 7278251
    [No Abstract]   [Full Text] [Related]  

  • 53. Electrophysiological effects of some antidepressant drugs on canine cardiac Purkinje fibres.
    Bril A; Rochette L; Bertrand JP; Gautier P
    Cardiovasc Res; 1987 Nov; 21(11):783-9. PubMed ID: 3370662
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electrophysiological actions of lidocaine on canine ventricular muscle and Purkinje fibers.
    Davis LD; Temte JV
    Circ Res; 1969 May; 24(5):639-55. PubMed ID: 5770253
    [No Abstract]   [Full Text] [Related]  

  • 55. Electrophysiologic effects of pirmenol, its metabolite 2, and enantiomers, on cardiac Purkinje fibers.
    Lee JH; Rosen MR
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):416-22. PubMed ID: 7504132
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of disopyramide on electrophysiologic properties of canine cardiac purkinje fibers.
    Danilo P; Hordof AJ; Rosen MR
    J Pharmacol Exp Ther; 1977 Jun; 201(3):701-10. PubMed ID: 864604
    [No Abstract]   [Full Text] [Related]  

  • 57. Beta-adrenergic augmentation of flecainide-induced conduction slowing in canine Purkinje fibers.
    Cragun KT; Johnson SB; Packer DL
    Circulation; 1997 Oct; 96(8):2701-8. PubMed ID: 9355912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interrelationships between external potassium concentration and lidocaine: effects on canine Purkinje fiber.
    Obayashi K; Hayakawa H; Mandel WJ
    Am Heart J; 1975 Feb; 89(2):221-6. PubMed ID: 1114948
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of therapeutic concentrations of diphenylhydantoin on transmembrane potentials of normal and depressed Purkinje fibers.
    Rosen MR; Danilo P; Alonso MB; Pippenger CE
    J Pharmacol Exp Ther; 1976 Jun; 197(3):594-604. PubMed ID: 932992
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of ouabain on the electrophysiological properties of subendocardial Purkinje fibers surviving in regions of acute myocardial infarction.
    Brennan FJ; Bonn JR
    Am Heart J; 1980 Aug; 100(2):201-12. PubMed ID: 7405789
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.